
|Videos|March 28, 2016
Guidelines Pharmacists Should Refer to When Selecting a Novel Oral Anticoagulant
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about what clinical guidelines pharmacists should refer to when selecting a novel oral anticoagulant.
Advertisement
John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about what clinical guidelines pharmacists should refer to when selecting a novel oral anticoagulant.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
2
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
3
New CKD Outcome Set Tells Pharmacists What to Measure
4
GLP-1s and the HCM–Sleep Apnea–Obesity Connection
5





































































































